Bsx share

Dec 1, 2023 · Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion. .

Acting on our mission to advance science for life. See how we are working to build a better and more equitable future for all. View our 2022 Performance Report. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.MARLBOROUGH, Mass., Feb. 2, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational 1 basis and 15.1 percent on an organic 2 basis, all compared to the prior year period.

Did you know?

May 20, 2023 · MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management ... The positive data demonstrated a low 0.37% rate of major adverse events at seven days following a WATCHMAN FLX implant or the time of hospital discharge, whichever was later.Boston Scientific Corp. 55.44. Delayed Data. As of Nov 29. -0.005 / -0.01%. Today’s Change. 43.84. Today ||| 52-Week Range. 55.83.

Today’s BSX share price, stock chart and announcements. View dividend history, insider trades and ASX analyst consensus.BSX 6% short puts. then New ATH buying calls Hey Everyone, The market has been doing so crazy things the last year. Here is a company that seems to be handling market turmoil well. BSX has recently retraced from the ATH of 47ish @ share. My personal view of BSX in the next couple of months are the following.Oct 4, 2023 · BSX (Brain Specific Homeobox) is a Protein Coding gene. Diseases associated with BSX include Jacobsen Syndrome and Exocervical Carcinoma . Gene Ontology (GO) annotations related to this gene include DNA-binding transcription factor activity and sequence-specific DNA binding . An important paralog of this gene is DLX5. Get Boston Scientific Corp (BSX) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, and financial report.The current Boston Scientific [ BSX] share price is $55.63. The Score for BSX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal. BSX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Dec 1, 2023 · 21.97. Very Bullish. Boston Scientific Share Price Live Today:Get the Live stock price of BSX Inc., and quote, performance, latest news to help you with stock trading and investing.Check out why ... With US$47.60 share price, Boston Scientific appears to be trading close to its estimated fair value Analyst price target for BSX is US$52.51, which is 10% above our fair value estimate ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Bsx share. Possible cause: Not clear bsx share.

If an investor was to purchase shares of BSX stock at the current price level of $55.40/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...Nov 30, 2023 · If an investor was to purchase shares of BSX stock at the current price level of $55.40/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

What's Next For Boston Scientific Stock After 5% Gains In A Week? The company reported revenue of $3.5 billion and adjusted earnings of $0.50 per share, compared to the consensus estimates of $3.4 billion and $0.48, respectively. 24 days ago - Forbes.May 19, 2023 · The second is share repurchases with any excess cash, he added. One of the latest examples of that tuck-in strategy is the company’s $615 million acquisition of gastrointestinal device maker Apollo Endosurgery, which closed during the quarter, CEO Mike Mahoney told the analysts. According to the issued ratings of 16 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 14 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $60.55 with a high price target of $66.00 and a low price target of $55.00.

tellus real estate Feb 16, 2022 · Looking at the bottom line, Boston Scientific reported adjusted earnings of $0.45 on a per share and adjusted basis, compared to $0.23 in the prior-year quarter. ... BSX stock appears to have some ... Discover historical prices for BSX stock on Yahoo Finance. View daily, weekly or monthly format back to when Boston Scientific Corporation stock was issued. galen hope reviewsotckx The Boston Scientific share price today is $55.63 Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BSX is experiencing buying pressure, which is a positive indicator for future bullish movement.Boston Scientific (BSX) In a report released yesterday, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific, with a price target of $60.00. The company’s ... is amazon a buy Dec 4, 2023 · Shares of BSX traded down $1.11 during trading hours on Monday, hitting $55.03. 1,228,860 shares of the company were exchanged, compared to its average volume of 8,026,681. The company has a ... hedge fund real estatesh ticker3c.ai stock price MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ... stock charting program Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion.1 Non-GAAP measure; excludes certain GAAP items. For reconciliations of non-GAAP financial measures to the most directly comparable GAAP figures, please refer to our Financial Disclaimers and Non-GAAP Reconciliations. instacart share pricetop gaining stock todayjnj stock split 2023 March 20, 2023 at 6:07 AM · 4 min read. Boston Scientific Corporation BSX is well poised for growth in coming quarters, backed by impressive value-added acquisitions. New strategic investments to ...Boston Scientific Corporation (NYSE:NYSE:BSX) Citi 2013 Global Healthcare Conference February 25, 2013 11:05 AM ETExecutivesJeffrey D.